Congress beefed up federal dollars to expand access to health care services in rural communities in the health and tax law signed in July by President Trump. The Rural Health Transformation program ...

The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced ...

Novo Nordisk (NVO) remains a strong buy in the weight loss/diabetes market despite challenges. Read here for an investment ...

The U.S. Centers for Medicare & Medicaid Services (CMS) released its delayed and much-anticipated CY 2026 home health final payment rule on Friday, ...

CVS Health (NYSE: CVS) has been a huge outperformer this year. The stock is up about 79% so far in 2025 -- move than five ...

CMS late on Friday afternoon released the 2026 Home Health Prospective Payment System Final Rule with final details for the next round of its national competitive bidding program (CBP), ...

Novo Nordisk A/S (NVO), though cheap at 13x forward earnings, is in my view a value trap, as growth is slowing and GLP-1 ...

Health insurers are pulling out of the Medicare Advantage market. Discover which areas will gain or lose the most, and what to do if your plan is canceled.

Skilled nursing operators are anxiously awaiting further findings from the Office of Inspector General after the federal watchdog said an initial audit found a provider had grossly abused the ...

Medicare Advantage insurers scored a Thanksgiving gift, as President Trump’s Medicare agency added back a bonus system that ...

In 2026, Social Security checks are getting bigger. That’s the good news. The bad news, however, is that retirees are likely to find that the Cost of Living Adjustment (COLA) they are expecting ...

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...